These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 27586169)
41. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D. Kutyifa V; Bloch Thomsen PE; Huang DT; Rosero S; Tompkins C; Jons C; McNitt S; Polonsky B; Shah A; Merkely B; Solomon SD; Moss AJ; Zareba W; Klein HU Heart Rhythm; 2013 Dec; 10(12):1770-7. PubMed ID: 23973954 [TBL] [Abstract][Full Text] [Related]
42. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy. Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186 [TBL] [Abstract][Full Text] [Related]
43. Differing effects of cardiac resynchronization therapy on long-term mortality in patient subgroups of MADIT-CRT defined by baseline conduction and 1-year post-treatment left ventricular remodeling. Goldstein RE; Haigney MC; Krone RJ; McNitt S; Zareba W; Moss AJ Heart Rhythm; 2013 Mar; 10(3):366-73. PubMed ID: 23183194 [TBL] [Abstract][Full Text] [Related]
44. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy. Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359 [TBL] [Abstract][Full Text] [Related]
45. Successful reduction of intraventricular asynchrony is associated with superior response to cardiac resynchronization therapy. Dreger H; Borges AC; Baumann G; Melzer C Cardiovasc Ultrasound; 2010 Sep; 8():35. PubMed ID: 20809960 [TBL] [Abstract][Full Text] [Related]
46. Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy. Gronda E; Genovese S; Padeletti L; Cacciatore F; Vitale DF; Bragato R; Innocenti L; Schiano C; Sommese L; De Pascale MR; Genovese L; Abete P; Donatelli F; Napoli C Cardiol J; 2015; 22(4):459-66. PubMed ID: 26325259 [TBL] [Abstract][Full Text] [Related]
50. Positive response to cardiac resynchronization therapy reduces arrhythmic events after elective generator change in patients with primary prevention CRT-D. Sebag FA; Lellouche N; Chen Z; Tritar A; O'Neill MD; Gill J; Wright M; Leclercq C; Rinaldi CA J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1368-75. PubMed ID: 25066404 [TBL] [Abstract][Full Text] [Related]
51. Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT). Lee AY; Moss AJ; Ruwald MH; Kutyifa V; McNitt S; Polonsky B; Zareba W; Ruwald AC Am J Cardiol; 2015 May; 115(10):1423-7. PubMed ID: 25817576 [TBL] [Abstract][Full Text] [Related]
52. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks. van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733 [TBL] [Abstract][Full Text] [Related]
53. Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience. Kutyifa V; Geller L; Bogyi P; Zima E; Aktas MK; Ozcan EE; Becker D; Nagy VK; Kosztin A; Szilagyi S; Merkely B Eur J Heart Fail; 2014 Dec; 16(12):1323-30. PubMed ID: 25379962 [TBL] [Abstract][Full Text] [Related]
54. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy). Kydd AC; Khan FZ; Watson WD; Pugh PJ; Virdee MS; Dutka DP JACC Heart Fail; 2014 Jun; 2(3):205-12. PubMed ID: 24952685 [TBL] [Abstract][Full Text] [Related]
55. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. Ypenburg C; van Bommel RJ; Borleffs CJ; Bleeker GB; Boersma E; Schalij MJ; Bax JJ J Am Coll Cardiol; 2009 Feb; 53(6):483-90. PubMed ID: 19195605 [TBL] [Abstract][Full Text] [Related]
56. Left Ventricular Lead Location and Long-Term Outcomes in Cardiac Resynchronization Therapy Patients. Kutyifa V; Kosztin A; Klein HU; Biton Y; Nagy VK; Solomon SD; McNitt S; Zareba W; Goldenberg I; Roka A; Moss AJ; Merkely B; Singh JP JACC Clin Electrophysiol; 2018 Nov; 4(11):1410-1420. PubMed ID: 30466845 [TBL] [Abstract][Full Text] [Related]
57. Close connection between improvement in left ventricular function by cardiac resynchronization therapy and the incidence of arrhythmias in cardiac resynchronization therapy-defibrillator patients. Schaer BA; Osswald S; Di Valentino M; Soliman OI; Sticherling C; ten Cate FJ; Jordaens L; Theuns DA Eur J Heart Fail; 2010 Dec; 12(12):1325-32. PubMed ID: 20923856 [TBL] [Abstract][Full Text] [Related]
58. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE). Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796 [TBL] [Abstract][Full Text] [Related]
59. Predictors and outcomes of "super-response" to cardiac resynchronization therapy. Killu AM; Grupper A; Friedman PA; Powell BD; Asirvatham SJ; Espinosa RE; Luria D; Rozen G; Buber J; Lee YH; Webster T; Brooke KL; Hodge DO; Wiste HJ; Glikson M; Cha YM J Card Fail; 2014 Jun; 20(6):379-86. PubMed ID: 24632340 [TBL] [Abstract][Full Text] [Related]
60. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure. Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR; Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]